Rocket


Overview
Financials
News + Filings
Key Docs
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Odyssey Health, Inc. (ODYY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Resignation/termination of a director
10/05/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ASSET PURCHASE AGREEMENT",
"Oragenics to Acquire Odyssey Health’ s Neurological Drug Technology Pipeline Including Concussion Drug Candidate"
08/18/2023 8-K Quarterly results
07/07/2023 8-K Quarterly results
06/28/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Speranza Therapeutics announces letter of intent to merge with public company, Odyssey Health Inc. BOCA RATON, Fla. June 28, 2023 Speranza Therapeutics, Inc. , a medical technology company dedicated to providing better patient outcomes by addressing large, underserved markets, and Odyssey Health Inc or , a publicly traded medical device company, have executed a non- binding letter of intent to merge."
04/04/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT #5 TO CONVERTIBLE PROMISSORY NOTE",
"AMENDMENT #5 TO PROMISSORY NOTE"
01/13/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
01/06/2023 8-K Resignation/termination of a director
01/03/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT #4 TO CONVERTIBLE PROMISSORY NOTE",
"FORM OF AMENDMENT #4 TO PROMISSORY NOTE",
"AMENDMENT #1 TO PROMISSORY NOTE"
11/25/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
09/30/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program Las Vegas Nevada, Sept. 30, 2022 Odyssey Health, Inc. , f/k/a Odyssey Group International, Inc., a company focused on developing a unique drug to treat concussion has decided to dissolve its sports advisory board. The sports advisory members have been outspoken advocates for concussion prevention and for the importance of finding responsible treatments. We created the advisory board to increase awareness of our mission to bring a much-needed pharmaceutical for a condition that currently has no FDA approved treatment. We have recently completed a Phase I human trial where our drug was proven to be safe and well tolerated. We are excited about the potential of initiating a Phase II trial to determine the e..."
09/30/2022 8-K Quarterly results
09/15/2022 8-K Other Events  Interactive Data
08/18/2022 8-K Quarterly results
07/29/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
04/20/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Odyssey Health Welcomes United States Vice Admiral Timothy Szymanski to Military Advisory Board"
04/20/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities  Interactive Data
04/14/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT TO CONVERTIBLE PROMISSORY NOTE"
02/18/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT TO CONVERTIBLE PROMISSORY NOTE"
01/10/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation Odyssey Group International, Inc. , a company focused on developing unique, life-saving medical products, today announced that it has received a donation in the amount of $500,000 in partnership with the Erase PTSD Now organization and the Glenn Greenberg and Linda Vester Foundation. These funds will be used to progress the Phase 1 human clinical trials for drug candidate PRV-002 for the treatment of concussion. “We are honored to have formed a partnership with Erase PTSD Now and to have been chosen by Glenn and Linda’ s Foundation for such a tremendous gift to advance our drug trials. We are currently in a Phase I safety study and these fun..."
12/30/2021 8-K Other Events  Interactive Data
12/27/2021 8-K Other Events  Interactive Data
12/27/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PROMISSORY NOTE"
11/04/2021 8-K Other Events
10/26/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Securities Purchase Agreement by and between Odyssey Group International, Inc. and Lincoln Park Capital, LLC",
"Warrant issued to Lincoln Park Capital, LLC, exercisable for 833,333 shares"
10/21/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy